Alzheimer Disease
Alzheimer's Disease and Emerging Treatments Analyzed in Neurotech Insights
Published in Genetics and Environmental Business Week, September 4th, 2008
This month's feature article reviews the competing hypotheses around the cause of Alzheimer's disease including: the beta amyloid theory, tau hypothesis, the APOE4 and vascular theory, anti-inflammatories, memory enhancers, neuroprotection and mitochondrial boosters.
The issue also discusses leading therapies in development from the following companies: Accera, Allon Therapeutics (TSX: NPC), Amgen, Avera, Ceregene,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Acrongenomics, Inc.
Acrongenomics Increases its Shareholding in and Restructures Relationship with Molecular Vision - Apoptosis
AposenseŽ [18f]-ml-10 To Be Radiolabelled By Iba for Multi-center Clinical Trials - Asuragen, Inc.
Asuragen, Inc. Launches Signature NPM1 Mutations RUO*: a Rapid Multiplex Assay for the Detection of NPM1 Mutations - Ataxia
Boston University and the Center for Human Genetics, Inc. Announce Change in Testing Services - BioTime, Inc.
BioTime, Inc.'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS and Embryonic Stem Cell Differentiation Technology - Cancer
New cancer study findings have been reported by researchers at Boehringer Ingelheim GmbH - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
